Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04016623 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of Invigor Toric 1-Day Contact Lenses

A NA study of Astigmatism, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04016623 is a NA study of Astigmatism that has completed, run by CooperVision. The registered enrollment target is 10 participants, below the 106-participant average among 31 other Astigmatism trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04016623, a NA study of Astigmatism, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

An evaluation of the clinical performance of the 1-day toric test contact lens compared to the 1-day toric control contact lens over one hour of lens wear.

Conditions Studied

Interventions

  • DEVICE 1-day toric test contact lens
  • DEVICE 1-day toric control contact lens

Study Locations (1)

Indiana

  • Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University - Bloomington

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-05-06
Est. Completion 2019-06-04
Phase NA

Sponsor

CooperVision

64 total trials

What the Registry Record Tells You About NCT04016623

The ClinicalTrials.gov registry entry for NCT04016623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 106-participant average among 31 other Astigmatism trials with a reported enrollment target (91% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Astigmatism appearing as the primary indexed condition, and to 2 interventions - of which 1-day toric test contact lens is the first listed.

NCT04016623 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT04016623 about?

NCT04016623 is a clinical study titled "Clinical Evaluation of Invigor Toric 1-Day Contact Lenses". An evaluation of the clinical performance of the 1-day toric test contact lens compared to the 1-day toric control contact lens over one hour of lens wear.

What is the current status of trial NCT04016623?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-05-06. Estimated completion is 2019-06-04.

What conditions does trial NCT04016623 study?

This clinical trial studies the following conditions: Astigmatism.

What interventions are being tested in trial NCT04016623?

The interventions under investigation include: 1-day toric test contact lens (DEVICE), 1-day toric control contact lens (DEVICE).

Who is sponsoring clinical trial NCT04016623?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04016623 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Astigmatism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.